Custom service
Transporter Preparation
SLC transporters kept in a bilayer, where transport is possible.
Transporters are different from receptors in a way that dictates the whole workflow: their function is movement, not binding. A ligand-binding assay on a purified transporter confirms the protein exists, not that it transports. Only a preparation in a sealed bilayer with a defined gradient can demonstrate transport, which is why transporter work converges on reconstitution rather than on detergent micelles.
Expression is screened across hosts — insect cells for production, Pichia for scale, HEK293 where a mammalian lipid environment matters — with surface expression and substrate binding checked in intact cells. Many SLC transporters need specific lipids, particularly cholesterol and anionic phospholipids, and the lipid composition of the reconstitution is treated as an experimental variable rather than a fixed recipe.
The deliverable is usually proteoliposomes or nanodiscs with a controlled protein-to-lipid ratio. Transport is measured with radiolabelled or fluorescent substrate uptake, driven by an imposed gradient — pH, membrane potential or counter-substrate — and validated against the same transporter in intact cells. Affinity, turnover and inhibitor sensitivity follow from the same assay.
Transporter preparation serves inhibitor screening outside cells, antibody discovery against conformational epitopes, and biophysical work that needs a defined bilayer composition.
Where the question is pharmacology, a stable cell line with a uptake assay is faster and closer to physiology. Purified and reconstituted transporter is justified when the bilayer composition must be controlled or when cells cannot support the assay.
Batches are released with surface expression data, extraction and purification chromatograms, proteoliposome or nanodisc characterisation (size, protein-to-lipid ratio), and transport measurements with intact-cell comparison. For ABC transporters, ATPase activity accompanies the transport data.
Service Highlights
- Transport-first validation. Substrate uptake measured on the final preparation, with intact-cell comparison as the reference.
- Lipid composition as a variable. Cholesterol, PIP2 and anionic lipids screened for their effect on transport activity.
- Gradient-driven assays. Uptake driven by pH, potential or counter-substrate gradients, matching the transporter's physiological driving force.
- Controlled reconstitution. Protein-to-lipid ratio measured and reported, since it determines whether kinetics are interpretable.
- Inhibitor-ready format. Proteoliposome assays validated for inhibitor testing, with IC50 against reference compounds where available.
- ABC transporter support. ATP-dependent transporters prepared with the ATPase assay as the companion readout.
How the work runs
Construct design
Full-length transporter with tags placed where they do not disturb the transport cycle; accessory proteins included where biology requires.
Expression screening
Hosts compared by surface expression and substrate binding in intact cells.
Extraction
Mild detergents with lipid retention; extraction efficiency and substrate binding tracked through the process.
Purification
Affinity capture and SEC with lipid supplements, holding binding activity throughout.
Reconstitution
Assembly into liposomes or nanodiscs at controlled ratios, with the lipid composition optimised for transport.
Transport assay
Substrate uptake measured under the driving gradient, compared with intact-cell transport, with inhibitor sensitivity where relevant.
Specifications & timeline
- Target classes
- SLC transporters (glucose, amino acid, neurotransmitter, organic anion), ABC transporters
- Expression hosts
- Sf9/High Five, Pichia pastoris, HEK293
- Formats
- Proteoliposomes, MSP nanodiscs, detergent micelles for binding work
- Assays
- Uptake with radiolabelled or fluorescent substrate, ATPase for ABC transporters, inhibitor IC50
- Timeline
- 8–16 weeks per target
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.